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CDKN1C and NAP1L4 in human CDKN1C/KCNQ1OT1 imprinted domain are two key candidate genes responsible for BWS
(Beckwith-Wiedemann syndrome) and cancer. In order to increase understanding of these genes in pigs, their cDNAs are
characterized in this paper. By the IMpRH panel, porcine CDKN1C and NAP1L4 genes were assigned to porcine chromosome
2, closely linked with IMpRH06175 and with LOD of 15.78 and 17.94, respectively. By real-time quantitative RT-PCR and
polymorphism-based method, tissue and allelic expression of both genes were determined using F1 pigs of Rongchang and
Landrace reciprocal crosses. The transcription levels of porcine CDKN1C and NAP1L4 were signiﬁcantly higher in placenta than
in other neonatal tissues (P<0.01) although both genes showed the highest expression levels in the lung and kidney of one-
month pigs (P<0.01). Imprinting analysis demonstrated that in pigs, CDKN1C was maternally expressed in neonatal heart,
tongue, bladder, ovary, spleen, liver, skeletal muscle, stomach, small intestine, and placenta and biallelically expressed in lung and
kidney, while NAP1L4 was biallelically expressed in the 12 neonatal tissues examined. It is concluded that imprinting of CDKN1C
is conservative in mammals but has tissue speciﬁcity in pigs, and imprinting of NAP1L4 is controversial in mammalian species.
1.Introduction
Genomic imprinting, in which the monoallelic expression
of certain genes depends on the parent of origin due to
epigenetic regulation in somatic cells, is vital for fetal growth
and development, function of the placenta, and postnatal
behaviour in mammals. Many researches have reported that
disruption of genomic imprinting is responsible for congen-
ital disorders, cancers, and other types of diseases such as
BWS (Beckwith-Wiedemann syndrome) and PWS (Prader-
Willi syndrome) [1–4]. Currently, about 2114 imprinted
transcripts and 600 potentially imprinted genes have been
estimated in the genome of mice [5, 6], of which about 160
imprinted genes have been described (http://igc.otago.ac.nz/
home.html), but only several genes have been reported to be
imprinted in pigs. Therefore, it is necessary to characterize
more imprinted genes in the pig to oﬀer new data and in-
sights to the comparative genome research as well as porcine
functional genomics.
Most imprinted genes aggregate within the genome
and gene order and imprinting in each imprinted domain
show considerable similarity between mouse and human
[7, 8]. It has been reported that CDKN1C and KCNQ1OT1
reside in an imprinted cluster on human 11p15.5, syntenic
to mouse distal chromosome 7. Genes in this region in-
clude OSBPL5, CARS, NAP1L4, PHLDA2, SLC22A18,
SLC22A18AS,CDKN1C,KCNQ1DN,KCNQ1OT1,KCNQ1,
TSSC4, CD81, and ASCL2 [8]. Imprinting disruption of the
CDKN1C/KCNQ1OT1 domain is involved in the develop-
ment of both BWS and cancer [8].
CDKN1C (cyclin-dependant kinase inhibitor) and
NAP1L4 (nucleosome assembly protein 1-like 4) are two of
particular interest genes within the CDKN1C/KCNQ1OT1
imprinted cluster in human and mouse. The CDKN1C,
also known as p57Kip2, encodes a cyclin-dependent kinase
inhibitor (CDKI) that belongs to the CIP/KIP family, and
it is a putative tumor suppressor gene [9, 10]. Mutations
in CDKN1C have been identiﬁed in approximately 5–20%
of patients with BWS [11, 12], and mice with maternally
inherited deletion of CDKN1C showed some features of
BWS [13], while in sporadic cancers and embryonal tumors,2 Journal of Biomedicine and Biotechnology
mutations of CDKN1C are very rare [14–18]. NAP1L4, also
called NAP-2, codes for a protein with homology to NAPs
involved in regulating gene expression by delivering histones
from the cytoplasm to the chromatin assembly machinery
[19]. NAP1L4 associates with the processes of restraining
fetal growth and causing fetal lethality [20]. These results
suggest that CDKN1C and NAP1L4 are two of the important
genes responsible for the development of BWS and cancer
[8].
At present, there are a lot of reports about the imprint-
ing status of CDKN1C and NAP1L4 both in human and
mouse.CDKN1Cisexpressedfromthematernalallele,while
NAP1L4 is biallelically expressed in all the tissues except
maternal expression in mouse placenta [21]. In the pig,
CDKN1C is expected of maternal expression [22]. Despite
of these advances, data on porcine CDKN1C and NAP1L4
are limited. Hence, tissue expression patterns and imprinting
status of porcine CDKN1C and NAP1L4 were investigated
in this work. This study will contribute to increasing the
understanding of functional importance of CDKN1C and
NAP1L4 in pigs.
2.MaterialsandMethods
2.1. Tissue Samples and cDNA Preparations. Reciprocal
crossings were performed using 8 Landrace (LD) and 8 in-
digenous China breed Rongchang (RC) pigs (4 boars and
4s o w so fe a c hb r e e d ) .T h e s eb o a r sa n ds o w sh a v en oc o m -
mongrandparents.Tissuesincludingheart,stomach,skeletal
muscle, kidney, lung, liver, small intestine, bladder, tongue,
spleen,fat,ovaryandplacentawerecollectedfrom23F1pigs,
which included 10 neonatal pigs within 24h after birth (5
pigs from three parent pairs of LD × RC and 5 pigs from
three parent pairs of RC × LD) as well as 7 and 6 one-
monthpigsfromfourparentpairsofLD ×RC and RC ×LD,
respectively. Ear tissues of parental pigs for genomic DNA
isolationandgenotypingofCDKN1CandNAP1L4werealso
collected. Tissue samples were stored at −80◦C until use.
Total RNA was isolated from frozen tissues using TRIzol
reagent (Invitrogen, San Diego, USA) and treated with
DNase I (TaKaRa, Japan). Reverse transcription was carried
outusingAMVreversetranscriptaseXL(TaKaRa,Japan)and
oligo(dT) primer at 42◦C for 50min, 70◦C for 15min. Both
reactants with and without reverse transcriptase were used as
positive and negative samples, respectively, for gene cloning
and imprinting analysis.
2.2. Molecular Cloning of CDKN1C and NAP1L4. The cDNA
sequences of human genes CDKN1C (NM 000076) and
NAP1L4 (NM 005969) were used to search for available ex-
pressed sequence tags (ESTs) in the pig ESTs database using
BLASTn program (http://www.ncbi.nlm.nih.gov/BLAST/).
The homologous sequences, sharing greater than 80% iden-
tity and match of at least 100bp, were assembled into ESTs
contigs for primer design. Primer pair CDF1/R1 was used
for CDKN1C, while NAF1/R1 for NAP1L4 (Table 1). To
obtain full-length cDNA of the two genes, 5 -a n d3  -RACE
wereperformedwithSMARTRACEcDNAAmpliﬁcationKit
(Clontech, USA) and the RNA LA PCR Kit (TaKaRa, Japan),
respectively, according to the supplier’s instructions. For 5 -
RACE, sequence-speciﬁc primers 5 CDGSP1 and 5 CDGSP2
(nested) were designed for CDKN1C, while 5 NAGSP1 and
5 NAGSP2 (nested) for NAP1L4. For 3 -RACE, sequence-
speciﬁc primers, 3 NAGSP1 and 3 NAGSP2 nested were
designed for NAP1L4.
Thermocycling conditions of PCR reactions were initial
denaturation at 94◦C for 5min, followed by 35 cycles of
denaturation at 94◦C for 30s, annealing at 53–60◦Cf o r3 0s
(Table 1), and extension at 72◦C for 30s, with a ﬁnal exten-
sion at 72◦C for 10min. PCR products were then sequenced
at commercial service (Invitrogen, Shanghai, China).
2.3. Radiation Hybrid (RH) Mapping. To obtain intron se-
quenceforRHmapping,alignmentofporcineCDKN1Cand
NAP1L4 with human corresponding genes (NM 000076,
NM 005969) was performed. According to the consensus
sequences, primers INF1/R1 and INF2/R2 (Table 1)w e r ed e -
signed for ampliﬁcation of CDKN1C intron 2 and NAP1L4
intron 3. Primer pairs MF1/R1 and MF2/R2 (Table 1)b a s e d
on the introns above were used for PCR typing of the
porcine radiation hybrid (IMpRH) panel, which were kindly
provided by INRA (France) [23]. PCR was performed in
duplicateinatotalvolumeof10μL,containing25ngIMpRH
DNA samples, 0.3μMo fe a c hp r i m e r ,7 5μMo fe a c hd N T P ,
1.5mM MgCl2, and 1U Taq DNA polymerase (TaKaRa,
Japan). The PCR conditions were as follows: 3min at 94◦C,
followed by 35 cycles of 30s at 94◦C, 30s at 60◦C, 30s at
72◦C, and an extra 7min extension at 72◦C. In addition,
PCR reactions were carried out with pig genomic DNA (as
positivecontrol)andwithoutDNA(asnegativecontrol).The
statistical analyses of the PCR results were performed with
the IMpRH mapping tool accessible at http://rhdev.toulouse
.inra.fr/. Two-point and multiple-point RH analyses were
used for the identiﬁcation of linkage groups using LOD score
threshold of 5.0.
2.4. Heterozygous Pig Identiﬁcation and Imprinting Assay.
SNPs of CDKN1C and NAP1L4 genes were searched via
alignment of Landrace and Rongchang cDNA sequences.
Genotyping was performed for single-nucleotide polymor-
phisms (SNPs) in each gene using genomic DNA of the 23 F1
individuals. SNPs were detected by direct sequencing of PCR
products using primer pairs IJF1/R1, IJF2/R2 (Table 1), for
CDKN1C and NAP1L4, respectively.
The allelic expression pattern of each gene was analyzed
by RT-PCR of total RNA from samples heterozygous for
SNPs. PCR products by each of the primer pairs described
above were then sequenced in both directions. To eliminate
the possibility of genomic DNA contamination in the RT-
PCR, primers β-actinF/R spanning intron 3 of pig β-actin
were designed based on porcine β-actin (AY550069).
2.5. Quantitative Real-Time PCR. Quantitative real-time
PCR was performed with SYBR Premix Ex TaqTM II kit in
a Bio-Rad iQ 5 machine (USA). Primers QF1/R1, QF2/R2
and QF3/R3 (Table 1) were used to amplify a 136, 128, andJournal of Biomedicine and Biotechnology 3
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165bp cDNA for CDKN1C, NAP1L4, and RPL32 (ribosomal
protein L32), respectively. Melting curve analysis (60–95◦C)
was used for assessing ampliﬁcation speciﬁcity. Total RNA
extracted from each tissue sample was reverse transcribed
using PrimeScript RTase and oligo(dT) (TaKaRa, Japan).
Reactions were performed in triplicate in a total volume of
25μL. The reaction volume of 25μL contained 12.5μL SYBR
Premix Ex Taq II (TaKaRa, Japan), 0.4 μMe a c ho fp r i m e r s ,
and 2.5μL template cDNA. A standard curve for analysis of
the expression data was derived for each single gene from a
serialdilutionofthepool ofcDNAsamples.Theendogenous
control gene RPL32, which showed stable expression in our
published data [24], was used. Relative expression of each
gene was determined by using the 2−ΔΔCt method. ANOVA
analysis and multiple comparisons were applied to each gene
toverifywhethertheexpressiondiﬀerencebetween tissues or
ages was signiﬁcant.
3. Results
3.1. Sequence Analysis and Localization of Porcine CDKN1C
and NAP1L4. The full-length cDNA spanning 1171bp was
assembled for porcine CDKN1C after sequencing the PCR
products of primers CDF1/R1 as well as 5 -RACE (GenBank
accession no. HQ679903). Sequence analysis showed that
the gene contained an open reading frame (ORF) of 786bp
(from nt 162 to nt 947 of HQ679903), encoding a 261-
amino acid protein. The ORF is 79% identical in amino acid
sequenceand85%identicalinnucleotidesequencetohuman
sequences (NM 000076). The full-length cDNA of NAP1L4
is 2655bp (HQ679902) with 470bp 5 -UTR, 1024bp 3 -
UTR, and 1161bp ORF, which codes for 386 amino ac-
ids. The porcine NAP1L4 utilizes a polyadenylation site
(ATTAAA), located at position 2617 of HQ679902. The ORF
is 94% identical in amino acid sequence and 86% identical in
nucleotide sequence to human sequences (NM 005969).
In human and mouse, CDKN1C and NAP1L4 genes are
closely linked [8]. The chromosomal location of porcine
CDKN1C and NAP1L4 was determined by the IMpRH panel
[23]. The two-point analysis showed that both CDKN1C
(LOD 15.78, distance 0.15cR, and retention frequency 16%)
andNAP1L4(LOD17.94,distance0.11cR,andretentionfre-
quency 19%) were closely linked to IMpRH06175, on Sus
scrofa chromosome 2 (SSC2). The multiple-point analysis
demonstrated that CDKN1C was linked to 311840215 (up-
per marker, dist 0.34cR) and IMpRH06175 (lower marker,
dist 0.14cR), while NAP1L4 was linked to 311840215 (upper
marker, dist 0.36cR) and IMpRH06175 (lower marker, dist
0.10cR).
3.2. Expression and Imprinting of CDKN1C. The expression
patterns of porcine CDKN1C were determined by relative
quantitative real-time PCR analysis with total RNAs isolated
from tissues of 5 neonatal and 7 one-month hybrids of LD ×
RC. For each age, RNA of a tissue was used as a biological
repeat. In neonatal pigs, the mRNA level of CDKN1C in
placenta was amazingly high (P<0.01), while it was very
low in other tissues and with no diﬀerences between them
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Figure 1: Tissue expression of porcine CDKN1C (a) and NAP1L4
(b). The expression values are normalized to RPL32 and expressed
as mean ± SE. Sp: spleen; Lu: lung; H: heart; K: kidney; T: tongue;
B: bladder; O: ovary; Li: liver; Sm: skeletal muscle; St: stomach; Si:
small intestine; P: placenta; F: fat. ABC-column means within 0 day
of age bearing diﬀerent superscripts diﬀers signiﬁcantly P<0.05
(lowercase) and P<0.01 (uppercase). ∗∗P<0.01.
(Figure 1(a)). In one-month-old pigs, highest expression
levels were observed in lung and kidney (P<0.01), followed
by skeletal muscle and heart (P<0.01). Fewer CDKN1C
transcripts were present in spleen, tongue, bladder, stomach,
liver, fat, and small intestine (P<0.01). Interestingly, tran-
script levels of porcine CDKN1C were upregulated in lung
and skeletal muscle, and downregulated in tongue, bladder,
and small intestine (P<0.01), but no diﬀerence was seen in
the other tissues after birth.
Alignment of Rongchang and Landrace sequences re-
vealedanSNP(A/G)atposition916ofCDKN1C(HQ679903).
Since the polymorphism did not provide any available RFLP
site, direct sequencing of RT-PCR products was used for the
discrimination of the expressed alleles. Sequencing of the
PCR products revealed that three newborn pigs from RC ×
LD and four from LD × RC occurred to be heterozygous
for the SNP, while their parental pigs were homozygous for
the allele A and G, respectively. The (RC × LD) F1 pigs only
expressed the Landrace allele G, and (LD × RC) F1 pigs only
expressed the Rongchang A allele in placenta (Figure 2(a))
as well as in tongue, bladder, ovary, spleen, liver, skeletal
muscle, stomach, and small intestine. However, biallelicJournal of Biomedicine and Biotechnology 5
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Figure2:MaternalorbiallelicexpressionofCDKN1C(a)andNAP1L4(b)in0-daypigs.RC:Rongchangpigs,LD:Landracepigs,P:placenta,
L: lung, K: kidney, Sm: skeletal muscle. Arrows indicate SNP sites.
expression of porcine CDKN1C was detected in lung and
kidney (Figure 2(a)).
3.3. Expression and Imprinting of NAP1L4. NAP1L4 was
ubiquitously expressed in porcine tissues. In the newborn
pigs, the expression level was signiﬁcantly higher in placenta
(P<0.01), followed by lung and skeletal muscle (P<0.05).
Fewer NAP1L4 transcripts were present in spleen, tongue,
bladder, ovary, liver, stomach and small intestine (P<0.05)
(Figure 1(b)). In contrast, at the age of one month, highest
levels of expression were observed in lung, heart, and kidney
(P<0.01) and the lowest expression were detected in spleen
and tongue (P<0.01). Compared with neonatal tissues,
expression of porcine NAP1L4 was upregulated in heart and
kidney, and downregulated in skeletal muscle (P<0.01), but
no signiﬁcant changes were seen in the other tissues.
A T/C SNP was detected between Rongchang and Lan-
drace pigs at position 2461 of NAP1L4 (HQ679902). A total
of ﬁve DNA samples from (RC × LD) F1 pigs and four DNA
samples from (LD × RC) F1 pigs were heterozygous for this
polymorphism, while their parents Landrace and Rongchang
pigs were C/C and T/T homozygotes, respectively. Direct se-
quencing of RT-PCR products demonstrated biallelic tran-
scription of NAP1L4 in lung, heart, kidney, tongue, bladder,
ovary, spleen, liver, skeletal muscle, stomach, small intestine,
and spleen of newborn pigs. The biallelic expression of por-
cine NAP1L4 in skeletal muscle is illustrated in Figure 2(b).
4. Discussion
In this study, CDKN1C and NAP1L4 genes were cloned,
and their chromosome location, expression patterns, and
imprinting were further analyzed for the ﬁrst time in pigs.
We use Rongchang and Landrace breeds for analysis of alle-
licexpressionduetothefactthatF1hybridsofthetwobreeds
are useful for detecting imprinting of genes [25]. Sequence
analysis showed that porcine CDKN1C and NAP1L4 have
high homology with those of human in amino acid and in
nucleic acid, respectively, and both genes are closely linked
in the region between markers IMpRH06175 and 311840215
on SSC2, syntenic to mice distal chromosome 7 and human
11p15.5 [8]. These results indicate that both genes are con-
servative in mammals.
CDKN1C is a potent inhibitor of several G1 cyclin/CDK
complexes, and its overexpression leads to cell-cycle arrest in
the G1 phase [26, 27]. The biological functions and distribu-
tion of CDKN1C in tissues have been widely investigated. In
human and mouse, researches have shown that CDKN1C is
mostlyexpressedinplacentaandatlowlevelsinothertissues,
while it is expressed in adult heart, brain, lung, skeletal
muscle, kidney, and pancreas [28, 29]. Recently, Shukla
et al. [30] revealed that mRNA levels of CDKN1C were al-
tered in placenta of intrauterine growth restriction (IUGR)
and alcohol-consuming dams compared to the controls;
thus, they were selected as the biomarkers for IUGR and
intrauterine alcohol exposure. Mutations in mouse Cdkn1c
result in the appearance of large thrombotic lesions in the
labyrinth zone in mouse placenta [31]. Our work showed
that the mRNA abundance of CDKN1C was highest in
porcine neonatal placenta, while its high expression levels
were detected in lung and kidney of one-month-old pigs.
In general, the expression pattern of porcine CDKN1C cor-
relates well with the human and mouse gene, and the high
levelsinexpressionofCDKN1Cinporcineplacentaillustrate6 Journal of Biomedicine and Biotechnology
its important roles in porcine placental growth and develop-
ment.
NAP1L4 has been found to be localized mainly to the
cytoplasm and a minor population of them to be in the
nucleus, mediating nucleosome formation [32]. Hu et al.
[33] found that NAP1L4 is ubiquitously expressed, showing
a threefold higher level of expression in testis than in other
tissues.Interestingly,ourworkalsoshowedthatNAP1L4was
ubiquitously expressed in porcine tissues, but higher expres-
sion of NAP1L4 was detected in neonatal placenta than in
the other tissues. As NAP1L4 mediates angiogenesis, and it is
signiﬁcantly higher expressed in red-feather Taiwan country
chickens of high egg productions than in the subpopulations
of low egg productions [34]. These studies indicate that the
functions of NAP1L4 contribute to reproduction perform-
ance in animals and may play a role in placental functions.
TherearesomereportsabouttheimprintingofCDKN1C
and NAP1L4. CDKN1C is expressed from maternal allele
in both human and mouse [8]. Mouse Nap1l4 is paternal-
ly repressed in placenta and biallelically expressed in other
embryo tissues [21], whereas biallelic expression of human
NAP1L4 can be detected in all tissues and ages tested by
Higashimoto et al. [8]. Like in humans, NAP1L4 in pigs was
biallelicallyexpressedinalltissuesdetectedinthisstudy.Fur-
thermore, our data showed maternal expression of porcine
CDKN1Cinheart,tongue,bladder,ovary,spleen,liver,skele-
tal muscle, stomach, small intestine and placenta, consistent
with previous data of greater expression of CDKN1C from
parthenote than from biparental samples [22]. The biallelic
expression of CDKN1C in lung and kidney in the pig diﬀers
from monoallelic expression in the same tissues in humans.
This is because the degree of imprinting is often tissue and
species speciﬁc because of diﬀerent epigenetic modiﬁcation
[35]. In humans and mice, it has been documented that
CDKN1C imprinting is regulated by KCNQ1OT1 antisense-
RNA transcript originating from intron 10 of the maternally
expressedKCNQ1(KvLQT1)gene[36].ACpGislandlocated
at the promoter of KCNQ1OT1, referred to as KvDMR1 or
KCNQ1 imprinting control region (ICR), is unmethylated
on the paternal allele and methylated on the maternal allele,
favouring expression of KCNQ1OT1 from the paternal allele
that leads to the propagation of silencing of neighboring
genes including CDKN1C. While the KCNQ1 ICR has not
been characterized in pigs, gene order and gene structure
within this cluster are highly conservative between human,
mouse, chicken, and tammar [37]. This information lends
support to the hypothesis that diﬀerent epigenetic modiﬁ-
cation of KCNQ1 ICR or other mechanisms terminatie the
KCNQ1OT1 transcripts in porcine lung and kidney. Further
studies are needed to elucidate the mechanisms associated
with biallelic expression of CDKN1C in lung and kidney of
pigs.
5. Conclusions
The full-length cDNA of porcine NAP1L4 and cDNA includ-
ing 5 -UTR and ORF of porcine CDKN1C was cloned in this
study. Both porcine CDKN1C and NAP1L4 were mapped
on SSC2, closely linked to IMpRH06175. Imprinting analysis
showed that NAP1L4 was biallelically expressed in the tissues
tested, while CDKN1C was maternally expressed in tissues
except lung and kidney in pigs, conﬁrming the results by
Bischoﬀ et al. [22] that CDKN1C is expected of maternal
expression. This study revealed a novel imprinted domain in
the pig and provided data for further investigation of func-
tional importance of porcine CDKN1C and NAP1L4.
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